NCT07070492View on ClinicalTrials.gov

Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens

NANot yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Cataract and IOL SurgeryEpi-retinal Membrane
Interventions
DEVICE

cataract surgery

cataract surgery receiving Vivity IOL or standard mono focal controls

PROCEDURE

retinal surgery

Retinal surgery for visually significant epiretinal membrane

All Listed Sponsors
lead

Debbie Kuo, MD

OTHER

NCT07070492 - Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens | Biotech Hunter | Biotech Hunter